1. Home
  2. CYTK vs ITRI Comparison

CYTK vs ITRI Comparison

Compare CYTK & ITRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • ITRI
  • Stock Information
  • Founded
  • CYTK 1997
  • ITRI 1977
  • Country
  • CYTK United States
  • ITRI United States
  • Employees
  • CYTK N/A
  • ITRI N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • ITRI Electrical Products
  • Sector
  • CYTK Health Care
  • ITRI Industrials
  • Exchange
  • CYTK Nasdaq
  • ITRI Nasdaq
  • Market Cap
  • CYTK 5.6B
  • ITRI 5.0B
  • IPO Year
  • CYTK 2004
  • ITRI 1993
  • Fundamental
  • Price
  • CYTK $32.48
  • ITRI $107.87
  • Analyst Decision
  • CYTK Buy
  • ITRI Strong Buy
  • Analyst Count
  • CYTK 19
  • ITRI 10
  • Target Price
  • CYTK $77.33
  • ITRI $126.80
  • AVG Volume (30 Days)
  • CYTK 2.4M
  • ITRI 547.7K
  • Earning Date
  • CYTK 05-06-2025
  • ITRI 05-01-2025
  • Dividend Yield
  • CYTK N/A
  • ITRI N/A
  • EPS Growth
  • CYTK N/A
  • ITRI 57.53
  • EPS
  • CYTK N/A
  • ITRI 5.48
  • Revenue
  • CYTK $19,218,000.00
  • ITRI $2,444,546,000.00
  • Revenue This Year
  • CYTK $55.84
  • ITRI $3.20
  • Revenue Next Year
  • CYTK $646.96
  • ITRI $5.52
  • P/E Ratio
  • CYTK N/A
  • ITRI $19.78
  • Revenue Growth
  • CYTK 412.21
  • ITRI 7.10
  • 52 Week Low
  • CYTK $31.67
  • ITRI $90.11
  • 52 Week High
  • CYTK $68.44
  • ITRI $124.90
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 31.23
  • ITRI 54.97
  • Support Level
  • CYTK $34.88
  • ITRI $105.36
  • Resistance Level
  • CYTK $43.51
  • ITRI $112.67
  • Average True Range (ATR)
  • CYTK 2.00
  • ITRI 3.14
  • MACD
  • CYTK -0.67
  • ITRI 0.04
  • Stochastic Oscillator
  • CYTK 6.84
  • ITRI 61.48

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About ITRI Itron Inc.

Itron Inc provides solutions that measure, manage, and analyze energy and water use. It operates under the Itron brand and manages and reports under three operating segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment includes hardware products used for measurement, control, or sense that do not have communications capability embedded for use with broader Itron systems. The Networked Solutions segment includes a combination of communicating devices, network infrastructure, and associated application software designed and sold as a complete solution. The Outcome segment includes their value-added, enhanced software and services which manage, organize, analyze, and interpret data to improve decision-making and maximize operational profitability.

Share on Social Networks: